Orthogonal Thinker is a pioneering biotechnology startup founded in 2016 in the United States. The company's vision involves developing innovative products to revolutionize the traditional pharmaceutical industry, creating a new standard referred to as "Farma," which stands for Food as Medicine. The company's core focus includes Psilocybin & Wellness, Whole Food, and Cannabis | Hemp | CBD, demonstrating a commitment to leveraging nature's most effective health solutions while upholding transparency and quality standards. Notably, Orthogonal Thinker recently secured a significant $6.00M Seed Round investment on 29 April 2020, with backing from Republic capital and Das & Co. This investment will likely facilitate the advancement and distribution of Maui Raw production, innovation, and the development of psychoactive compounds, aligning with the company's ambitious goal of ushering in a new era of health and wellness.
No recent news or press coverage available for Orthogonal Thinker.